Form 4: ClearPoint Neuro CFO Danilo D'Alessandro Reports Acquisition of Restricted Stock Units

ClearPoint Neuro's CFO, Danilo D'Alessandro, reports the acquisition of 8,291 restricted stock units.

Summary

• On March 11, 2024, Danilo D'Alessandro, the Chief Financial Officer of ClearPoint Neuro, Inc. (CLPT), acquired 8,291 restricted stock units (RSUs).
• These RSUs represent a contingent right to receive one share of CLPT common stock per unit.
• The RSUs vest in two tranches: 50% on the first anniversary of the grant date and the remaining 50% on the second anniversary.
• Following this transaction, D'Alessandro directly owns 8,291 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard transaction. The acquisition of RSUs by an executive is generally viewed as a positive, but it's a routine event.

Positives

• The acquisition of restricted stock units by a key executive can be seen as a positive sign, aligning the executive's interests with those of the shareholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The acquisition of RSUs by the CFO could have a slightly positive impact on shareholder confidence.

Key Dates